Acute loss of vision during therapy of chronic hepatitis C

J. P. Salgado; R. Khoramnia; M. M. Maier; C. P. Lohmann; C. Winkler Von Mohrenfels

doi:10.1007/s00347-010-2327-0

Acute loss of vision during therapy of chronic hepatitis C

Translated title of the contribution: Acute loss of vision during therapy of chronic hepatitis C

J. P. Salgado
, R. Khoramnia
, M. M. Maier
, C. P. Lohmann
, C. Winkler Von Mohrenfels

Department of Ophthalmology

University of Würzburg
Technical University of Munich

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

A patient undergoing combined therapy of chronic hepatitis C with pegylated interferon-α-2a (PEG-IFN-α-2a) and ribavirin suddenly developed severe loss of visual acuity. A central vein occlusion with macular edema was found and intravitreal injections of bevacizumab were initiated. Retinal occlusion is a known complication of therapy with pegylated interferon-α-2a and ribavirin. An interdisciplinary assessment of patients treated for a chronic hepatitis C as well as an early anti-VEGF administration can be helpful in the therapy of this complication of chronic hepatitis C.

Translated title of the contribution	Acute loss of vision during therapy of chronic hepatitis C
Original language	English
Pages (from-to)	561-564
Number of pages	4
Journal	Ophthalmologe
Volume	108
Issue number	6
DOIs	https://doi.org/10.1007/s00347-010-2327-0
State	Published - Jun 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Bevacizumab
Central vein occlusion
Hepatitis C
Macular edema
Pegylated interferon-α-2a

Access to Document

10.1007/s00347-010-2327-0

Cite this

@article{720d9065cb3040099d5366393561f0ce,

title = "Acute loss of vision during therapy of chronic hepatitis C",

abstract = "A patient undergoing combined therapy of chronic hepatitis C with pegylated interferon-α-2a (PEG-IFN-α-2a) and ribavirin suddenly developed severe loss of visual acuity. A central vein occlusion with macular edema was found and intravitreal injections of bevacizumab were initiated. Retinal occlusion is a known complication of therapy with pegylated interferon-α-2a and ribavirin. An interdisciplinary assessment of patients treated for a chronic hepatitis C as well as an early anti-VEGF administration can be helpful in the therapy of this complication of chronic hepatitis C.",

keywords = "Bevacizumab, Central vein occlusion, Hepatitis C, Macular edema, Pegylated interferon-α-2a",

author = "Salgado, \{J. P.\} and R. Khoramnia and Maier, \{M. M.\} and Lohmann, \{C. P.\} and \{Von Mohrenfels\}, \{C. Winkler\}",

year = "2011",

month = jun,

doi = "10.1007/s00347-010-2327-0",

language = "English",

volume = "108",

pages = "561--564",

journal = "Ophthalmologe",

issn = "0941-293X",

publisher = "Springer Medizin",

number = "6",

}

TY - JOUR

T1 - Acute loss of vision during therapy of chronic hepatitis C

AU - Salgado, J. P.

AU - Khoramnia, R.

AU - Maier, M. M.

AU - Lohmann, C. P.

AU - Von Mohrenfels, C. Winkler

PY - 2011/6

Y1 - 2011/6

N2 - A patient undergoing combined therapy of chronic hepatitis C with pegylated interferon-α-2a (PEG-IFN-α-2a) and ribavirin suddenly developed severe loss of visual acuity. A central vein occlusion with macular edema was found and intravitreal injections of bevacizumab were initiated. Retinal occlusion is a known complication of therapy with pegylated interferon-α-2a and ribavirin. An interdisciplinary assessment of patients treated for a chronic hepatitis C as well as an early anti-VEGF administration can be helpful in the therapy of this complication of chronic hepatitis C.

AB - A patient undergoing combined therapy of chronic hepatitis C with pegylated interferon-α-2a (PEG-IFN-α-2a) and ribavirin suddenly developed severe loss of visual acuity. A central vein occlusion with macular edema was found and intravitreal injections of bevacizumab were initiated. Retinal occlusion is a known complication of therapy with pegylated interferon-α-2a and ribavirin. An interdisciplinary assessment of patients treated for a chronic hepatitis C as well as an early anti-VEGF administration can be helpful in the therapy of this complication of chronic hepatitis C.

KW - Bevacizumab

KW - Central vein occlusion

KW - Hepatitis C

KW - Macular edema

KW - Pegylated interferon-α-2a

UR - https://www.scopus.com/pages/publications/79959327594

U2 - 10.1007/s00347-010-2327-0

DO - 10.1007/s00347-010-2327-0

M3 - Article

AN - SCOPUS:79959327594

SN - 0941-293X

VL - 108

SP - 561

EP - 564

JO - Ophthalmologe

JF - Ophthalmologe

IS - 6

ER -

Acute loss of vision during therapy of chronic hepatitis C

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this